Back
Appian Corp. 10K Form
Sell
49
APPN
Appian Corp.
Last Price:
$39.35
Seasonality Move:
7.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | APPN/Appian Corp. Quarterly |
| 2020-05-07 | 10Q | APPN/Appian Corp. Quarterly |
| 2020-02-20 | 10K | APPN/Appian Corp. Annual |
| 2019-10-31 | 10Q | APPN/Appian Corp. Quarterly |
| 2019-08-08 | 10Q | APPN/Appian Corp. Quarterly |
| 2019-05-02 | 10Q | APPN/Appian Corp. Quarterly |
Receive APPN News And Ratings
See the #1 stock for the next 7 days that we like better than APPN
APPN Financial Statistics
Sales & Book Value
| Annual Sales: | $617M |
|---|---|
| Cash Flow: | $18.1M |
| Price / Cash Flow: | 40.24 |
| Annual Sales: | $-0.66 |
| Price / Book: | 40.5 |
Profitability
| EPS (TTM): | -0.09970 |
|---|---|
| Net Income (TTM): | $-7.3M |
| Gross Margin: | $455M |
| Return on Equity: | -2892.71% |
| Return on Assets: | -1.23% |
Appian Corp. Earnings Forecast
Key Appian Corp. Financial Ratios
-
The Gross Profit Margin over the past 11 years for APPN is 73.75%.
-
The Selling, General & Administrative Expenses for APPN have been equal to 60.41% of Gross Profit Margin.
-
The Research & Development expenses have been 25.12% of Revenue.
-
The Net Earning history of APPN is -14.95% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
Appian Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | APPN |
| CUSIP: | 03782L |
| Website: | appian.com |
Debt
| Debt-to-Equity Ratio: | -6.32 |
|---|---|
| Current Ratio: | 1.1 |
| Quick Ratio: | 1.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 51.17 |
APPN Technical Analysis vs Fundamental Analysis
Sell
49
Appian Corp. (APPN)
is a Sell
Is Appian Corp. a Buy or a Sell?
-
Appian Corp. stock is rated a SellThe current Appian Corp. [APPN] share price is $39.39. The Score for APPN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.